Congress’s PBM reforms won’t end America’s drug pricing woes. Here’s what they would do.

Stat News

26 July 2023 - Law makers in Congress generally agree that there’s something very broken with the way America pays for prescription drugs. 

They’re focused this summer on reining in pharmacy middlemen to make the system fairer — but none of their many proposals will actually tackle the core dynamic that has incentivised higher drug prices.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing